Top 100 Medical Startups to Watch in 2026
The medical startup scene is seeing major investment across various specializations. Companies are tackling everything from elder care to neurotechnology.
For example, Neuralink has raised $1.3 billion to develop brain-computer interfaces. Meanwhile, newer companies like Aster are addressing specific needs like OB/GYN clinic management.
Below is our list of 100 Medical startups worth keeping an eye on.
Failory's Top 10 Picks
Honor has built the world's largest home care network, connecting local agencies and care professionals with families seeking support for aging loved ones. Their technology platform helps modernize agency operations and provides caregivers with tools to deliver high quality in-home care.
| Headquarters | Concord, California, United States |
| Year Founded | 2014 |
| Founders | Cameron Ring, Monica Lo, Sandy Jen, Seth Sternberg |
| Funding Amount | $625M |
| Startup Size | Large Team (251-1,000) |
| Last Funding Status | Debt Financing |
| Top Investors | Andreessen Horowitz, Alumni Ventures, 8VC, Slow Ventures, Thrive Capital |
OpenEvidence builds an AI-powered search engine designed for medical professionals to find clinical answers. The platform provides evidence-based support for treatment decisions by rapidly analyzing medical literature.
| Headquarters | Cambridge, Massachusetts, United States |
| Year Founded | 2021 |
| Founders | Daniel Nadler, Zachary Ziegler |
| Funding Amount | $317M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Series B |
| Top Investors | Sequoia Capital, Coatue, Conviction, Thrive Capital, Kleiner Perkins |
Neuralink develops brain-computer interfaces designed to treat neurological disorders. Their technology aims to restore autonomy for people with paralysis by enabling them to control computers and mobile devices directly with their thoughts.
| Headquarters | Fremont, California, United States |
| Year Founded | 2016 |
| Founders | Dongjin Seo, Elon Musk, Max Hodak |
| Funding Amount | $1.3B |
| Startup Size | Large Team (251-1,000) |
| Last Funding Status | Venture Round |
| Top Investors | Valor Equity Partners, Lightspeed Venture Partners, Sequoia Capital, Craft Ventures, Founders Fund |
Midi Health runs a virtual clinic delivering expert care for women navigating perimenopause, menopause, and other midlife hormonal changes. Their service connects patients with trained specialists who develop personalized treatment plans to address a wide range of symptoms.
| Headquarters | Los Angeles, California, United States |
| Year Founded | 2021 |
| Founders | Joanna Strober, Sharon Meers |
| Funding Amount | $152M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series C |
| Top Investors | Felicis, GV, Muse Capital, Operator Collective, Emerson Collective |
Ambience Healthcare has built an AI operating system that automates critical workflows for healthcare organizations, from clinical documentation to coding. Their suite of tools helps reduce the administrative burden on clinicians, allowing them to focus more on patient care.
| Headquarters | San Francisco, California, United States |
| Year Founded | 2020 |
| Founders | Michael Ng, Nikhil Buduma |
| Funding Amount | $319.3M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series C |
| Top Investors | Andreessen Horowitz, Oak HC/FT, Kleiner Perkins, Georgian, Liquid 2 Ventures |
Aster builds an AI-powered operating system specifically for OB/GYN and women’s health practices. The platform is designed to streamline clinic operations, automate clinical documentation, and improve the patient experience.
| Headquarters | San Francisco, California, United States |
| Year Founded | 2023 |
| Founders | Fifi Kara |
| Funding Amount | $2.4M |
| Startup Size | Founding Team (1-10) |
| Last Funding Status | Pre-Seed |
| Top Investors | Octopus Ventures, Zeal Capital Partners, Everywhere Ventures, Cake Ventures, Cornerstone VC |
OrganOx builds a transportable medical device that keeps donor organs warm and functional outside the body. Their technology is designed to extend the time an organ is viable for transplant, improving the quality of the organ and increasing the chances of a successful surgery.
| Headquarters | Oxford, Oxfordshire, United Kingdom |
| Year Founded | 2008 |
| Founders | Peter Friend |
| Funding Amount | $207M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Venture Round |
| Top Investors | Amadeus Capital Partners, HealthQuest Capital, Business Growth Fund, Soleus Capital, Intuitive Ventures |
MoldCo has built a digital health platform for mold exposure care. Their service connects patients with specialized consultations, at-home testing, and personalized treatment plans.
| Headquarters | Boston, Massachusetts, United States |
| Year Founded | 2023 |
| Founders | Ariana Thacker |
| Funding Amount | $11M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Seed |
| Top Investors | SALT, Cantos, Collaborative Fund, Starship Ventures, Boost VC |
Thyme Care created a value-based care model that provides comprehensive navigation and support for cancer patients. They partner with health plans and oncologists to guide individuals through their treatment journey, aiming to improve both the experience and outcomes.
| Headquarters | Nashville, Tennessee, United States |
| Year Founded | 2020 |
| Founders | Bobby Green, Robin Shah |
| Funding Amount | $274M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series D |
| Top Investors | Andreessen Horowitz, Bessemer Venture Partners, Town Hall Ventures, Foresite Capital, AlleyCorp |
Avenzo Therapeutics develops next-generation oncology therapies for patients with cancer. Their team advances a portfolio of promising clinical-stage treatments designed to address significant unmet needs in cancer care.
| Headquarters | San Diego, California, United States |
| Year Founded | 2022 |
| Founders | Athena Countouriotis, Mohammad Hirmand |
| Funding Amount | $841.9M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Series B |
| Top Investors | OrbiMed, New Enterprise Associates, INCE Capital, SR One, Lilly Asia Ventures |
90 Additional Medical Startups Worth Following
Our top 10 picks offer a glimpse into a much larger movement. Combined, the companies on our full list have raised over $20 billion, tackling big problems in areas like biotech and AI.
You'll find a mix of newcomers and more established names. Here are the other companies making a mark on the medical industry.
| Startup | Main Industry | Year Founded | Amount Raised | Last Funding Round |
|---|---|---|---|---|
 Nest Health | Education | 2021 | $31.5M | Series A |
 Medable | Healthcare | 2015 | $506.6M | Series D |
 Daymark Health | Healthcare | 2022 | $57.5M | Series A |
 Modern Animal | AgTech | 2019 | $210M | Series D |
 Isomorphic Labs | AI | 2021 | $601.7M | Venture Round |
 Shields Health Solutions | Biotech | 2012 | $3.5B | Corporate Round |
 Nalu Medical | Healthcare | 2014 | $250.9M | Venture Round |
 SetPoint Medical | Biotech | 2007 | $496.4M | Series D |
 Predoc | Analytics | 2022 | $36.4M | Series A |
 Optain | AI | 2023 | $38M | Series A |
 Isaac Health | Healthcare | 2021 | $17.5M | Series A |
 Aidoc | AI | 2016 | $414M | Venture Round |
 Talkiatry | Healthcare | 2019 | $242M | Series C |
 Treeline Biosciences | Biotech | 2021 | $1.1B | Series A |
 League | Enterprise | 2014 | $271.1M | Venture Round |
 Grow Therapy | Healthcare | 2020 | $178M | Series C |
 Penguin Ai | AI | 2024 | $25M | Series A |
 Function Health | Healthcare | 2022 | $56M | Series B |
 Revalia Bio | Biotech | 2023 | $19.5M | Seed |
 Chapter | Healthcare | 2013 | $184M | Series D |
 Massive Bio | AI | 2015 | $23.8M | Series B |
 Harbor Health | Healthcare | 2022 | $255.5M | Series B |
 Galvanize Therapeutics | Healthcare | 2015 | $248.5M | Series C |
 Pearl | AI | 2019 | $69M | Series B |
 Ultima Genomics | Biotech | 2016 | $600M | Venture Round |
 VedaBio | Biotech | 2021 | $65M | Series A |
 Cedar | Fintech | 2016 | $419.4M | Series D |
 Fountain Life | AI | 2020 | $115.1M | Series B |
 Goodpath | Healthcare | 2019 | $30.5M | Series A |
 AltrixBio | Biotech | 2019 | $6.2M | Series A |
 Conceivable Life Sciences | AI | 2022 | $103.1M | Series A |
 Rocket Doctor | Healthcare | 2020 | $3.8M | Seed |
 Imagine Pediatrics | Education | 2022 | $104.6M | Series B |
 ViCentra | Healthcare | 2013 | $180.9M | Series D |
 DNAnexus | Biotech | 2009 | $472.6M | Series H |
 Pluto Health | Healthcare | 2020 | $8.9M | Seed |
 Willow | Healthcare | 2014 | $144.3M | Series D |
 Tennr | AI | 2021 | $161M | Series C |
 Star Therapeutics | Healthcare | 2018 | $315M | Series D |
 ADARx Pharmaceuticals | Biotech | 2019 | $332M | Venture Round |
 Hinge Bio | Biotech | 2015 | $30.2M | Series A |
 Sword Health | AI | 2015 | $493.5M | Venture Round |
 Vyome Therapeutics | Biotech | 2010 | $78.5M | Venture Round |
 Cellares | Biotech | 2019 | $355M | Series C |
 Proscia | AI | 2014 | $129.8M | Series D |
 BillionToOne | Biotech | 2016 | $425.9M | Series D |
 Judi Health | Healthcare | 2017 | $588M | Series F |
 Subtle Medical | AI | 2017 | $59.2M | Venture Round |
 EGenesis | Biotech | 2014 | $456M | Series D |
 Ritual | Retail | 2015 | $40.5M | Series B |
 Sunrise | Healthcare | 2015 | $49.5M | Venture Round |
 Ensoma | Biotech | 2019 | $258M | Venture Round |
 Abridge | AI | 2018 | $757.5M | Series E |
 Kindbody | Enterprise | 2018 | $306.3M | Venture Round |
 Elation Health | Healthcare | 2010 | $108.5M | Series D |
 SafeHeal | Healthcare | 2015 | $91M | Series C |
 Fort Health | Healthcare | 2022 | $14.3M | Seed |
 AusperBio | Biotech | 2019 | $237M | Series B |
 Truemeds | Healthcare | 2019 | $176.8M | Series C |
 Lindus Health | Biotech | 2021 | $79.5M | Grant |
 Boomerang Medical | Biotech | 2021 | $38M | Series B |
 HAYA Therapeutics | Biotech | 2017 | $1.1B | Grant |
 Click Therapeutics | Biotech | 2012 | $1B | Series C |
 BetterNight | Sports | 1995 | $52.6M | Series C |
 Roam Robotics | Sports | 2012 | $12.2M | Venture Round |
 RDS | Healthcare | 2020 | $22M | Series A |
 Autonomize AI | AI | 2022 | $32M | Series A |
 MedSetGo | Healthcare | 2022 | $2.4M | Seed |
 Alvogen | Healthcare | 2009 | $769M | Debt Financing |
 MapLight Therapeutics | Biotech | 2018 | $640.6M | Series D |
 Lykos Therapeutics | Healthcare | 2014 | $150M | Series B |
 Sequel | Healthcare | 2020 | $5M | Seed |
 Leal Therapeutics | Healthcare | 2021 | $75M | Series A |
 Emulate | Biotech | 2013 | $271.3M | Series F |
 Kromatid | Biotech | 2007 | $28.1M | Series C |
 DermaSensor | Biotech | 2009 | $51.9M | Series B |
 Full-Life Technologies | Biotech | 2021 | $187.3M | Series C |
 Ortivity | Healthcare | 2022 | $200M | Private Equity |
 EnsiliTech | Biotech | 2022 | £8.8M | Seed |
 Alchemab Therapeutics | Biotech | 2019 | $117.6M | Series A |
 Scene Health | Healthcare | 2008 | $36.4M | Grant |
 Dewpoint Therapeutics | Biotech | 2018 | $346.1M | Series D |
 Openwater | AI | 2016 | $76M | Venture Round |
 Restor3d | Manufacturing | 2017 | $291.7M | Series B |
 Altos Labs | Biotech | 2021 | $3B | Series A |
 Qure AI | AI | 2016 | $125.3M | Series D |
 ProVerum Medical | Healthcare | 2016 | $122.2M | Series B |
 Ronovo Surgical | Healthcare | 2019 | $135.8M | Series D |
 Electronic Caregiver | Healthcare | 2009 | $74M | Venture Round |
 Elemeno Health | Healthcare | 2016 | $29.2M | Convertible Note |
